Biological Information
Background Information:
Serotonin 5-HT receptors belong to the superfamily of G protein-coupled seven transmembrane proteins with the exception of the 5-HT₃ subtype, which belongs to the ligand gated cation superfamily of receptors. G-protein-coupled receptors constitute one of the major signal transduction systems in eukaryotic cells. Coding sequences for these receptors, in those regions believed to contribute to the agonist-antagonist binding site, are strongly conserved across mammalian species. Serotonin 5-HT₂ receptors are widely distributed in the central nervous system and peripheral tissues. The 5-HT₂ receptor class couples preferentially to Gq/G₁₁ to increase hydrolysis of inositol phosphates and elevate cytosolic [Ca²⁺]. Agonists of the 5HT₂ʙ receptor stimulate heart valve cell growth leading to cardiac valvulopathy and primary pulmonary hypertension. Antagonists prevent primary pulmonary hypertension and have been shown to prevent agonist-induced heart hypertrophy in rodents. Receptor antagonism may be useful for the treatment of migraine headache.
No. of Assays on Panel:
2
Assays on Panel:
Family
GPCR
Name
5-HT2B Human Serotonin GPCR Cell Based Agonist IP1 LeadHunter Assay - TW
Item
355260-0
Protein
5-HT2B
Organism
Human
Assay Sub Type
Cell Based
Family
GPCR
Name
5-HT2B Human Serotonin GPCR Cell Based Antagonist IP1 LeadHunter Assay - TW
Item
355260-1
Protein
5-HT2B
Organism
Human
Assay Sub Type
Cell Based
Family:
GPCR
Sub Family:
Serotonin
Class:
Class A
Protein Name:
5-HT2B
Uniprot Number:
P41595
Protein Aliases:
5-HT2B|Serotonin receptor 2B
Gene Name:
HTR2B
Gene ID:
3357
Gene Aliases:
5-HT(2B)|5-HT2B
Accession Number:
NM_000867
Organism:
Human
Construct Details:
Full Length, Recombinant
Cell Type:
CHO-K1
Assay Information
Assay Type:
Functional
Assay Sub Type:
Cell Based
Functional Mode:
Agonist & Antagonist
Detection Method:
TR-FRET
Measured Response:
Fluorescence
Testing Information
Procedure Summary:
Human recombinant serotonin 5-HT₂ʙ receptor stably expressed in CHO-K1 cells are used. Test compound or vehicle is incubated with the cells in stimulation buffer of IP₁ Gq kit for 30 minutes at 37°C. The reaction is evaluated for IP₁ levels by TR-FRET. Test compound-induced increase of IP₁ production by 50 percent or more (≥50%) relative to the 1 µM serotonin response indicates possible serotonin 5-HT₂ʙ receptor agonist activity. Test compound-induced inhibition of 20 nM serotonin-induced response in IP₁ levels by 50 percent or more (≥50%) indicates receptor antagonist activity.
Incubation:
30 min at 37°C
Control Inhibitor:
SB-206553 hydrate
Control Activator:
Serotonin (5-HT)
Criteria For Significance:
≥ 50% increase in IP-one relative to Serotonin response, ≥ 50% Inhibition of Serotonin-induced response
Test Concentration / Dose:
Compounds are screened at 10, 3, 1, 0.3, 0.1, 0.03, 0.01 and 0.003 μM
Test Sample Requirements:
75 μl of 10 mM stock or 1 mg (pre-weighed) powder (assuming FW ≦500 and purity 100%)
Minimum Order Quantity:
16
Turnaround Time
Standard:
20 Business Days
Reference Compound Data
Clinical Relevance
Therapeutic Area:
Cardiovascular
Additional Information
Brand:
LeadHunter
Testing Location:
Taiwan - Taipei
RELATED SOLUTIONS